BioCrine
  • Home
  • About Us
    • Company and People
    • Board of Directors
    • Management
    • Partners
  • Research Programs
    • Pipeline overview
    • Diabetes as a disease
    • Biocrine drug discovery strategy
    • Serum factor apoCIII
    • Insulin receptor isoforms
    • Calcium channels
    • Inositol pyrophosphates
  • InSight Technology
    • What is it?
    • How does it work?
    • Where can it be used?
  • News
  • Contact
Home » Uncategorized
Kallelse till årsstämma 22 juni 2021

Kallelse till årsstämma 22 juni 2021

Posted in: Uncategorized|May 19, 2021

Aktieägarna i Biocrine AB kallas härmed till årsstämma tisdagen den 22 juni 2021 kl 13:00 på Mäster Samuelsgatan 42, våning 10, Stockholm. Avstämningsdag:            2021-06-14 Sista anmälningsdag:    2021-06-18 För att minska risken för smittspridning kommer årsstämman 2021 att hållas kort och formell. Om möjlighet ges kommer aktieägarna att senare inbjudas till ett längre informationsmöte i …

Read more »
Metabolic derangements caused by a high-fat diet may be possible to eliminate

Metabolic derangements caused by a high-fat diet may be possible to eliminate

Posted in: Uncategorized|March 15, 2021

Intake of a high-fat diet leads to an increased risk for obesity, type 2 diabetes, cardiovascular diseases and fatty liver. A study in mice from Karolinska Institutet shows that it is possible to eliminate the deleterious effects of a high-fat diet by lowering the levels of apolipoprotein CIII (apoCIII), a key regulator of lipid metabolism. …

Read more »
Intraocular Pressure Monitoring Following Islet Transplantation to the Anterior Chamber of the Eye

Intraocular Pressure Monitoring Following Islet Transplantation to the Anterior Chamber of the Eye

Posted in: Uncategorized|November 28, 2019

Newly published article in Nano Letters about a novel technique to monitor intraocular pressure. Access to the abstract of this article is found HERE.

Read more »
Novel findings explain indirect regulation of glucose homeostasis

Novel findings explain indirect regulation of glucose homeostasis

Posted in: Uncategorized|August 21, 2019

As has recently been published on the Karolinska Institutet in Sweden’s website, professor Per-Olof Berggren and his colleagues have brought new insight into the role of the delta cells within the islet of Langerhans and how they may affect glucose homeostasis. Read more: Press release in English Nature Communications volume 10, Article number: 3700 (2019)   Nya fynd förklarar indirekt …

Read more »
Transplanted cells reveal early signs of type 1 diabetes

Transplanted cells reveal early signs of type 1 diabetes

Posted in: Uncategorized|May 15, 2019

On the web-site of Karolinska Institutet, there is a recent press release regarding a study published in Diabetologia, the scientific journal of the European Association for the Study of Diabetes (EASD). The leader of the study is professor Per-Olof Berggren. Read more: Press release in English Diabetologia 2019, Online ISSN 1432-0428   Transplanterade celler avslöjar tidiga …

Read more »
Per-Olof Berggren invald i the American Academy of Arts and Sciences

Per-Olof Berggren invald i the American Academy of Arts and Sciences

Posted in: Research group news, Uncategorized|October 4, 2018

Att Per-Olof Berggren, professor i experimentell endokrinologi vid Institutionen för molekylär medicin och kirurgi, har blivit invald i the American Academy of Arts and Sciences” står att läsa om i en pressrelease på Karolinska Institutets hemsida. Läs mera / Read more: Pressrelease på svenska Link in English American Academy of Arts and Sciences Elects 228 …

Read more »
The beta cell as a paradigm for advances in inositide research

The beta cell as a paradigm for advances in inositide research

Posted in: Uncategorized|September 20, 2012

Inositides are involved in regulating the insulin release from the pancreatic beta cell. New findings are published in Advances in Biological Regulation in September 2012. Inositides take an active part in regulating many vital processes in all cells in the organism. Depending on its primary function, cells have a specific footprint of what inositides they …

Read more »

Categories

Recent posts

  • Professor Berggren’s research publications
    Professor Berggren’s research publications June 20, 2022
  • Kallelse till årsstämma 22 juni 2021
    Kallelse till årsstämma 22 juni 2021 May 19, 2021
  • Metabolic derangements caused by a high-fat diet may be possible to eliminate
    Metabolic derangements caused by a high-fat diet may be possible to eliminate March 15, 2021
  • Intraocular Pressure Monitoring Following Islet Transplantation to the Anterior Chamber of the Eye
    Intraocular Pressure Monitoring Following Islet Transplantation to the Anterior Chamber of the Eye November 28, 2019
  • Noninvasive intravital high-resolution imaging of pancreatic neuroendocrine tumours
    Noninvasive intravital high-resolution imaging of pancreatic neuroendocrine tumours November 18, 2019
  • Novel findings explain indirect regulation of glucose homeostasis
    Novel findings explain indirect regulation of glucose homeostasis August 21, 2019
  • Transplanted cells reveal early signs of type 1 diabetes
    Transplanted cells reveal early signs of type 1 diabetes May 15, 2019
  • ERC grant for research on insulin-producing cells
    ERC grant for research on insulin-producing cells April 1, 2019
  • Short anti-rejection therapy protects transplants in diabetic animals
    Short anti-rejection therapy protects transplants in diabetic animals February 1, 2019
  • Per-Olof Berggren invald i the American Academy of Arts and Sciences
    Per-Olof Berggren invald i the American Academy of Arts and Sciences October 4, 2018

Biocrine AB

Box 3073

169 03 Solna, Sweden

Contact Us

info at biocrine.se

www.biocrine.com

Copyright © 2012 Biocrine AB. All Rights Reserved